Anavex announces long-lasting effect of anavex®3-71 preventing cognitive decline in a transgenic rat model of alzheimer's disease at aaic 2022

Anavex®3-71 effect is supported by biomarkers: decrease of extracellular a (abeta) deposition and reduced pathological inflammatory glial cell recruitment towards hippocampal neurons (p ≤ 0.01) anavex®3-71 effect is supported by biomarkers: decrease of extracellular a (abeta) deposition and reduced pathological inflammatory glial cell recruitment towards hippocampal neurons (p ≤ 0.01)
AVXL Ratings Summary
AVXL Quant Ranking